Dergiler / KONURALP TIP DERGİSİ / 2026 / Volume: 18 Issue: 3

Comparison of Machine Learning and Deep Learning-Based Survival Models: An Explainable Artificial Intelligence Approach

Esra Akaydın Gültürk(Sivas Cumhuriyet University, Faculty of Medicine, Department of Biostatistics)0000-0003-0978-3091
Emek Güldoğan(İnönü University, Faculty of Medicine, Department of Biostatistics and Medical Informatics)0000-0002-5436-8164
Sayfa
—
Yayın Tarihi
2026-10-27
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The explainability analyses confirmed clinically interpretable prognostic patterns and may inform the future development of clinical decision-support tools, pending external validation.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: To compare the predictive performance of ten survival models spanning statistical, tree-based, ensemble, kernel, and deep learning approaches on colon cancer survival data, and to interpret their predictions with explainable artificial intelligence methods.
📊
Temel Bulgular & Veri:Material and Methods: The colon dataset from the R survival package was used (n=888; events=430; event rate 48.4%).
💡
Sonuç & Katkı:The explainability analyses confirmed clinically interpretable prognostic patterns and may inform the future development of clinical decision-support tools, pending external validation.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Colon cancer · deep learning · explainable artificial intelligence

Abstract

Aim: To compare the predictive performance of ten survival models spanning statistical, tree-based, ensemble, kernel, and deep learning approaches on colon cancer survival data, and to interpret their predictions with explainable artificial intelligence methods. Material and Methods: The colon dataset from the R survival package was used (n=888; events=430; event rate 48.4%). Predictive performance was assessed by 5×3 nested cross-validation using Harrell's concordance index (C-index) and, for models with a native survival function, the integrated Brier score (IBS); time-dependent discrimination was examined with the cumulative/dynamic AUC. The stability of the point estimates was additionally summarised with 1000-iteration bootstrap 95% confidence intervals, which reflect apparent (within-sample) performance rather than generalisation. Explainability was addressed at three layers using SHAP, SurvSHAP(t), and SurvLIME. Results: In nested cross-validation the highest mean C-index values were very close across RSF (0.6600), XGBoost (0.6596), and DeepSurv (0.6578); RSF showed the most balanced performance, with the highest mean C-index, the lowest IBS (0.1740) and the highest time-dependent AUC (TD-AUC=0.7204). In the within-sample bootstrap ExtraSurvTrees and RSF attained the highest apparent C-index (0.7342 and 0.7307); however, these values are optimistically biased relative to the nested cross-validation estimates. SHAP identified the number of positive lymph nodes as the strongest prognostic factor, SurvSHAP(t) revealed time-dependent variation in feature importance, and SurvLIME produced patient-level interpretable risk profiles. Conclusion: Ensemble methods demonstrated consistent and stable cross-validated performance, whereas deep learning models, although competitive on average, carried a risk of instability on this small-to-medium dataset. The explainability analyses confirmed clinically interpretable prognostic patterns and may inform the future development of clinical decision-support tools, pending external validation.

🔖

Bu Makaleye Atıf Yap

Gültürk, E. A., Güldoğan, E. (2026). Comparison of Machine Learning and Deep Learning-Based Survival Models: An Explainable Artificial Intelligence Approach. KONURALP TIP DERGİSİ, Volume: 18 Issue: 3. https://doi.org/10.18521/ktd.1996338

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (50)

  1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63. doi:10.3322/caac.21834.
  2. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Türkiye kanser istatistikleri 2020 [İnternet]. Ankara: T.C. Sağlık Bakanlığı; 2025 [erişim tarihi: 21 Ekim 2026]. Erişim adresi: https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri
  3. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48. doi:10.3322/caac.21763.
  4. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457-81. doi:10.1080/01621459.1958.10501452.
  5. Cox DR. Regression models and life-tables. Journal of the Royal Statistical Society: Series B (Methodological). 1972;34(2):187-202. doi:10.1111/j.2517-6161.1972.tb00899.x
  6. Rajula HSR, Verlato G, Manchia M, Antonucci N, Fanos V. Comparison of conventional statistical methods with machine learning in medicine: diagnosis, drug development, and treatment. Medicina (Kaunas). 2020;56(9):455. doi:10.3390/medicina56090455.
  7. Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2(3):841-60. doi:10.1214/08-AOAS169.
  8. Katzman JL, Shaham U, Cloninger A, Bates J, Jiang T, Kluger Y. DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol. 2018;18(1):24. doi:10.1186/s12874-018-0482-1.
  9. Lee C, Zame W, Yoon J, Van der Schaar M. DeepHit: a deep learning approach to survival analysis with competing risks. In: Proceedings of the 32nd AAAI Conference on Artificial Intelligence. 2018 Feb 02-07, New Orleans, LA, USA: AAAI Press; 2018. p. 2314-21. doi:10.1609/aaai.v32i1.11842.
  10. Wang P, Li Y, Reddy CK. Machine learning for survival analysis: a survey. ACM Comput Surv. 2019;51(6):110. doi:10.1145/321430.
  11. Rudin C. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nat Mach Intell. 2019;1(5):206-15. doi:10.1038/s42256-019-0048-x.
  12. Lundberg SM, Lee SI. A unified approach to interpreting model predictions. In: Proceedings of the 31st International Conference on Neural Information Processing Systems. 2017 Dec 04-09, Long Beach, CA, USA: Curran Associates, Inc; 2017. p. 4765-74. doi:10.48550/arXiv.1705.07874.
  13. Ribeiro MT, Singh S, Guestrin C. Why should I trust you?: explaining the predictions of any classifier. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2016 Aug 13-17, San Francisco, CA, USA: Association for Computing Machinery; 2016. p. 1135-44. doi:10.1145/2939672.2939778.
  14. Krzyziński M, Spytek M, Baniecki H, Biecek P. SurvSHAP(t): time-dependent explanations of machine learning survival models. Knowledge Based Systems. 2023;262:110234. doi:10.1016/j.knosys.2022.110234.
  15. Kovalev MS, Utkin LV, Kasimov EM. SurvLIME: a method for explaining machine learning survival models. Knowledge Based Systems. 2020;203:106164. doi:10.1016/j.knosys.2020.106164.
  16. Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics. 2006;7:91. doi:10.1186/1471-2105-7-91.
  17. Christodoulou E, Ma J, Collins GS, Steyerberg EW, Verbakel JY, Van Calster B. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J Clin Epidemiol. 2019;110:12-22. doi:10.1016/j.jclinepi.2019.02.004.
  18. Huang Y, Li J, Li M, Aparasu RR. Application of machine learning in predicting survival outcomes involving real-world data: a scoping review. BMC Med Res Methodol. 2023;23(1):268. doi:10.1186/s12874-023-02078-1.
  19. Spooner A, Chen E, Sowmya A, Sachdev P, Kochan NA, Trollor J, et al. A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction. Sci Rep. 2020;10(1):20410. doi:10.1038/s41598-020-77220-w.
  20. Kim H, Park T, Jang J, Lee S. Comparison of survival prediction models for pancreatic cancer: Cox model versus machine learning models. Genomics Inform. 2022;20(2):e23. doi:10.5808/gi.22036.
  21. Moncada-Torres A, van Maaren MC, Hendriks MP, Siesling S, Geleijnse G. Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival. Sci Rep. 2021;11(1):6968. doi:10.1038/s41598-021-86327-7.
  22. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer; 2000.
  23. Fayyad U, Piatetsky-Shapiro G, Smyth P. From data mining to knowledge discovery in databases. AI Magazine. 1996;17(3):37-54. doi:10.1609/aimag.v17i3.1230.
  24. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322(6):352-8. doi:10.1056/NEJM199002083220602.
  25. Breiman L, Friedman J, Olshen RA, Stone CJ. Classification and regression trees. 1st ed. Boca Raton: Chapman & Hall/CRC; 1984.
  26. Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Statist. 2001;29(5):1189-232. doi:10.1214/aos/1013203451.
  27. Geurts P, Ernst D, Wehenkel L. Extremely randomized trees. Mach Learn. 2006;63(1):3-42. doi:10.1007/s10994-006-6226-1.
  28. Chen T, Guestrin C. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2016 Aug 13-17, San Francisco, CA, USA: Association for Computing Machinery; 2016. p. 785-94. doi:10.1145/2939672.293978.
  29. Akiba T, Sano S, Yanase T, Ohta T, Koyama M. Optuna: a next-generation hyperparameter optimization framework. In: Proceedings of the 25th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2019 Aug 04-08, New York, NY, USA: Association for Computing Machinery; 2019. p. 2623-31. doi:10.1145/3292500.3330701.
  30. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543-46.
  31. Graf E, Schmoor C, Sauerbrei W, Schumacher M. Assessment and comparison of prognostic classification schemes for survival data. Stat Med. 1999;18(17-18):2529-45. doi:10.1002/(sici)1097-0258(19990915/30)18:17/18 3.0.co;2-5.
  32. Uno H, Cai T, Tian L, Wei LJ. Evaluating prediction rules for t-year survivors with censored regression models. J Am Stat Assoc. 2007;102(478):527-37. doi:10.1198/016214507000000149.
  33. Efron B, Tibshirani RJ. An introduction to the bootstrap. 1st ed. New York: Chapman and Hall; 1993.
  34. Pachón-García C, Hernández-Pérez C, Delicado P, Vilaplana V. SurvLIMEpy: a Python package implementing SurvLIME. Expert Syst Appl. 2024;237:121620. doi:10.1016/j.eswa.2023.121620.
  35. Pölsterl S. Scikit-survival: a library for time-to-event analysis built on top of scikit-learn. J Mach Learn Res. 2020;21(212):1-6.
  36. Kvamme H, Borgan Ø, Scheel I. Time-to-event prediction with neural networks and Cox regression. J Mach Learn Res. 2019;20(129):1-30.
  37. Spytek M, Krzyziński M, Langbein SH, Baniecki H, Wright MN, Biecek P. Survex: an R package for explaining machine learning survival models. Bioinformatics. 2023;39(12):btad723. doi:10.1093/bioinformatics/btad723.
  38. Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, et al. From local explanations to global understanding with explainable AI for trees. Nat Mach Intell. 2020;2(1):56-67. doi:10.1038/s42256-019-0138-9.
  39. van der Ploeg T, Austin PC, Steyerberg EW. Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints. BMC Med Res Methodol. 2014;14:137. doi:10.1186/1471-2288-14-137.
  40. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):979-94. doi:10.5858/2000-124-0979-PFICC.
  41. Adatorwovor R, Ogunsanya ME, Huang B, Charnigo R, Abraham O. Comparison of machine learning models for colon cancer survival: predictive modeling approach. JMIR Cancer. 2025;11:e72665. doi:10.2196/72665.
  42. Kos FT, Cecen Kaynak S, Aktürk Esen S, Arslan H, Uncu D. Comparison of different machine learning models for predicting long-term overall survival in non-metastatic colorectal cancers. Cureus. 2024;16(12):e75713. doi:10.7759/cureus.75713.
  43. Chen Z, Ouyang H, Sun B, Ding J, Zhang Y, Li X. Utilizing explainable machine learning for progression-free survival prediction in high-grade serous ovarian cancer: insights from a prospective cohort study. Int J Surg. 2025;111(5):3224-34. doi:10.1097/JS9.0000000000002288.
  44. Zhong MY, Zou XC, Chen PH. Explainable machine learning predicts overall survival in female bladder cancer patients after radical cystectomy. Discov Oncol. 2025;17(1):175. doi:10.1007/s12672-025-04275-4.
  45. Ghasemi A, Hashtarkhani S, Schwartz DL, Shaban-Nejad A. Explainable artificial intelligence in breast cancer detection and risk prediction: a systematic scoping review. Cancer Innov. 2024;3(5):e136. doi:10.1002/cai2.136.
  46. Hounye AH, Xiong L, Hou M. Integrated explainable machine learning and multi-omics analysis for survival prediction in cancer with immunotherapy response. Apoptosis. 2025;30(1-2):364-88. doi:10.1007/s10495-024-02050-4.
  47. Wang X, Jiang Y, Yang S, Wang F, Zhang X, Wang W, et al. Foundation model for predicting prognosis and adjuvant therapy benefit from digital pathology in GI cancers. J Clin Oncol. 2025;43(32):3468-81. doi:10.1200/JCO-24-01501.
  48. Huang YQ, Chen XB, Cui YF, Yang F, Huang SX, Li ZH, et al. Enhanced risk stratification for stage II colorectal cancer using deep learning-based CT classifier and pathological markers to optimize adjuvant therapy decision. Ann Oncol. 2025;36(10):1178-89. doi:10.1016/j.annonc.2025.05.537.
  49. Zhao Z, Chen D, Wang R, Zhang X, Wen X, Zheng X, et al. Multiview deep-learning-enabled histopathology for prognostic and therapeutic stratification in stage II colorectal cancer: a retrospective multicenter study. PLoS Med. 2026;23(1):e1004614. doi:10.1371/journal.pmed.1004614.
  50. Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385-95. doi:10.1002/(sici)1097-0258(19970228)16:4 3.0.co;2-3.